Circadian variations of prostaglandins D2, E2, and F2 alpha in the cerebrospinal fluid of anesthetized rats
- PMID: 7646520
- DOI: 10.1006/bbrc.1995.2177
Circadian variations of prostaglandins D2, E2, and F2 alpha in the cerebrospinal fluid of anesthetized rats
Abstract
Circadian variations in the levels of prostaglandins (PGs) D2, E2, and F2 alpha were studied in the cerebrospinal fluid (CSF) of rats. We collected CSF samples from the cisterna magna of anesthetized rats at different clock-hours (1000, 1400, 1800, 2200, 0200, and 0600 hr), and measured the concentrations of the three PGs. PGD2, which appeared to be the most abundant among the three, showed a circadian variation; and the mean of the day-time levels (145 pg/ml) was significantly higher than that of the nighttime ones (111 pg/ml). Day/night variations were also noticed with the levels of PGE2 and PGF2 alpha; however, these levels remained 3-4 times lower than those of PGD2. The general day/night variation seen in the CSF concentration of PGD2 conforms well with the postulated role of PGD2 as an endogenous sleep-promoting factor acting on a certain brain surface area defined as its site of action.
Similar articles
-
Concentration of prostaglandin D2 in cerebrospinal fluid exhibits a circadian alteration in conscious rats.Biochem Mol Biol Int. 1995 Oct;37(3):431-7. Biochem Mol Biol Int. 1995. PMID: 8595382
-
CSF levels of prostaglandins, especially the level of prostaglandin D2, are correlated with increasing propensity towards sleep in rats.Brain Res. 1997 Mar 14;751(1):81-9. doi: 10.1016/s0006-8993(96)01401-1. Brain Res. 1997. PMID: 9098570
-
Permeability of brain structures and other peripheral tissues to prostaglandins D2, E2 and F2 alpha in rats.J Pharmacol Exp Ther. 1992 Sep;262(3):1110-20. J Pharmacol Exp Ther. 1992. PMID: 1527717
-
Molecular mechanisms of sleep-wake regulation: roles of prostaglandins D2 and E2.FASEB J. 1991 Aug;5(11):2575-81. FASEB J. 1991. PMID: 1907936 Review.
-
Pharmacological significance of prostaglandin E2 and D2 transport at the brain barriers.Adv Pharmacol. 2014;71:337-60. doi: 10.1016/bs.apha.2014.06.006. Epub 2014 Aug 22. Adv Pharmacol. 2014. PMID: 25307222 Review.
Cited by
-
Mrp4 confers resistance to topotecan and protects the brain from chemotherapy.Mol Cell Biol. 2004 Sep;24(17):7612-21. doi: 10.1128/MCB.24.17.7612-7621.2004. Mol Cell Biol. 2004. PMID: 15314169 Free PMC article.
-
The in vitro real-time oscillation monitoring system identifies potential entrainment factors for circadian clocks.BMC Mol Biol. 2006 Feb 16;7:5. doi: 10.1186/1471-2199-7-5. BMC Mol Biol. 2006. PMID: 16483373 Free PMC article.
-
Resetting of peripheral circadian clock by prostaglandin E2.EMBO Rep. 2005 Mar;6(3):256-61. doi: 10.1038/sj.embor.7400356. EMBO Rep. 2005. PMID: 15723041 Free PMC article.
-
Beta-trace protein (prostaglandin D synthase)--a stable and reliable protein in perilymph.Ger Med Sci. 2005 Jun 23;3:Doc04. Ger Med Sci. 2005. PMID: 19675721 Free PMC article.
-
Sleep neurobiology from a clinical perspective.Sleep. 2011 Jul 1;34(7):845-58. doi: 10.5665/SLEEP.1112. Sleep. 2011. PMID: 21731134 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous